drugset / Trial / NCT02105415

Ketamine / Propofol Admixture "Ketofol" at Induction in the Critically Ill Against Etomidate: KEEP PACE Trial

NCT02105415 ↗

Phase 2/3 Completed 160 enrolled Mayo Clinic
RandomizedParallel-groupTriple-blindTreatment

Summary

The hypothesis of this study is that a Ketamine / Propofol mixture will produce more stable hemodynamics as compared to Etomidate during emergent intubations in the intensive care unit. Patients that require a breathing tube to be placed in the ICU will be randomized to receIve either a Ketamine / Propofol mixture or Etomidate for sedation in order to place the breathing tube.

Timeline

Start
2014-04
Primary completion
2017-11-28
Completion
2018-08-01

Outcome

Missed primary endpoint

paper There was no statistically significant difference in mean arterial pressure change from baseline to 5 minutes postdrug administration PMID 31335755 ↗

paper ketamine/propofol admixture was not superior to a reduced dose of etomidate at preserving per-intubation hemodynamics PMID 31335755 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Etomidate Small molecule 0.15 mg/kg —
Subject Ketamine Small molecule 0.5 mg/kg —
Subject Propofol Small molecule 0.5 mg/kg —

Indications

No indication recorded.